Our Industrial Partners
Our industrial partner group represent a wide array of Scandinavian pharma and biotech companies. The companies provide SweDeliver with broad scientific and industrial competence and experience.
Affibody is a clinical stage Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™. Affibody is developing a portfolio of innovative drug projects and, in addition, offers the half-life extension technology, Albumod™, for outlicensing.
Apotek Produktion & Laboratorier AB
APL is one of the leading manufacturers of extempore pharmaceutical drugs in Europe, one of the leading contract manufacturer in Life Science in Scandinavia and an established partner to pharmacies for services and products. With 580 employees and four production plants, APL have resources for developing, analysing and producing medical products that improve or save lives.
AstraZeneca is a global, science-led biopharmaceutical business bringing innovative medicines to millions of patients. Our Gothenburg site is one of AstraZeneca's three strategic science centres. There we focus on cardiovascular/metabolic, respiratory diseases, strongly underpinned by drug delivery R&D.
CTC – Clinical Trial Consultants AB
CTC AB is a Swedish full-service CRO with clinical conduct in focus. Our mission is to facilitate clinical and translational research by providing our customers with cost-effective advice and implementation of early clinical trials (Phase 0 / I / IIa). CTC has three dedicated research clinics in Sweden, of which one is located at the Uppsala University Hospital, specialised in first time in human studies.
DelSiTech is an innovative drug delivery and development company that works with its partners to turn their active agents into novel and commercially attractive therapeutic drug products. DelSiTech provides the technology and expertise for solving drug delivery problems. The company’s technology is based on amorphous silica (SiO2) matrix and sol-gel encapsulation technique which have significant competitive advantages over other technologies.
Disruptive Materials AB
Disruptive Materials has developed a unique and patented mesoporous magnesium carbonate, Upsalite®, that can be used as a drug delivery system for poorly soluble drugs. Upsalite enables drugs to be loaded in an amorphous form into its’ nanometer sized pores. We have demonstrated high drug load and amorphous stability over time for several drugs.
Emplicure AB is a privately held Swedish research and product development focused pharmaceutical company. We develop new patentable pharmaceutical products based on drug delivery platform technologies originating from the interface between the materials and pharmaceutical sciences. Our products are all based on a large unmet medical need and existing pharmaceutical ingredients.
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and women’s health, and in specialty areas within gastroenterology and urology.
Iconovo is an innovative Swedish company that develops state-of the-art inhalation devices for licensing to customers. Every device is based on our proprietary platform but customized and adapted to the customer’s unique needs and requirements.
Janssen Pharmaceuticals, founded in 1953 is headquartered in Beerse, Belgium. Owned by Johnson & Johnson, Janssen is today one of the world’s leading research-based pharmaceutical companies, conducting research and development activities related to a wide range of human medical disorders.
MVIC is a full service CRO and partner specializing in inhaled drug delivery. Comprised of 26 Swedish member companies with long experience and high quality expertize in all aspects of inhalation product development.
Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science.
Orexo is a fully integrated specialty pharmaceutical company that develops improved pharmaceuticals based on innovative drug delivery technologies. Commercially the current focus is to help patients suffering from opioid dependence and pain while the research and development primarily is concentrated around addiction. The products are commercialized by Orexo in the US or via selected partners worldwide.
Orion Pharma is a globally operating Finnish pharmaceutical company who develops, manufactures and markets human and veterinary pharmaceuticals and APIs. Therapies targets central nervous system disorders, oncology and respiratory diseases.
Pharmetheus offers pharmacometric services supporting drug development of compounds in all clinical phases and in all therapeutic areas. Pharmetheus leverage on recent advances in model-based drug development methodology.
Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.